Giuseppe Ciliberti (@peppefercil) header
Giuseppe Ciliberti (@peppefercil) profile picture

Medical Doctor 🩺 Interventional Cardiologist 🫀 PhD Candidate

Joined September 2012
Photo by Giuseppe Ciliberti (@peppefercil)Photo by Giuseppe Ciliberti (@peppefercil)Photo by Giuseppe Ciliberti (@peppefercil)Photo by Giuseppe Ciliberti (@peppefercil)Photo by Giuseppe Ciliberti (@peppefercil)Photo by Giuseppe Ciliberti (@peppefercil)Photo by Giuseppe Ciliberti (@peppefercil)Photo by Giuseppe Ciliberti (@peppefercil)Photo by Giuseppe Ciliberti (@peppefercil)Photo by Giuseppe Ciliberti (@peppefercil)
Giuseppe Ciliberti retweeted
This #JACCCaseReports study highlights the importance of coronary artery assessment before & during transcatheter #PFO closure when anomalous coronary anatomy is present. bit.ly/4AcxcsJ
1
8
27
5,055
Giuseppe Ciliberti retweeted
International Day for Interventional Cardiology: the first coronary #angioplasty On 16 September 1977, Andreas Grüntzig & his team made history, and changed the lives of millions of patients forever. Standing on the shoulders of the giants that came before him, this transformative vision led to an entirely new field of medicine. What began nearly five decades ago with coronary angioplasty has grown into the broad field of interventional cardiology, transforming cardiovascular care through research, innovation and technological progress. As the field has evolved, so has the need to learn from experience, share knowledge and shape what comes next. Join us in 2027 at #EuroPCR to mark this landmark moment! 📅pcronline.com/Courses/EuroPC… #medicalhistory #interventionalcardiologist #cathlab #cathlabteam @NievesGonzalo1 @CuissetDr @nicolasdumonte1 @EmanueleBarba13
6
137
13
318
30,266
Giuseppe Ciliberti retweeted
Think AIR-STEMI the other way around: if halving the rate of non-culprit lesion revascularization (mostly stenosis >80%) truly reduces death and spontaneous myocardial infarction by 48%, this would mean that we have been harming our patients for years. What’s the catch?
3
8
4
31
22,909
Giuseppe Ciliberti retweeted
Presented at #ESCCongress: In patients with severe aortic stenosis and coronary artery disease, a strategy of transcatheter aortic-valve implantation before percutaneous coronary intervention was noninferior to PCI before TAVI for major clinical events at 1 year. Full TAVI PCI trial results: nej.md/3SlY3SF @escardio
1
78
5
211
38,171
Giuseppe Ciliberti retweeted
A study in The Lancet Healthy Longevity found that stopping statins in adults over 75 with no history of heart disease or stroke does not increase the risk of death within three years. Authors say further trials are needed to confirm these findings. 🔗 spkl.io/60147MUuk
5
91
16
273
95,664
Giuseppe Ciliberti retweeted
Among patients with multivessel coronary artery disease who were in stable condition 1 year after stenting, an additional year of DAPT led to a lower risk of ischemic events than aspirin alone, without increased bleeding. Full DAPT-MVD trial results: nej.md/4wLDIox Editorial: Balancing the Scales — Extended DAPT in Coronary Artery Disease nej.md/4gAVqpZ
3
79
4
223
30,674
Giuseppe Ciliberti retweeted
"he could’ve won in 2021, he should’ve won in 2022. he will finally climb to the top step" alex jacques' commentary always delivers 🙂‍↕️🙂‍↕️❤️
12
919
30
7,522
149,328
Giuseppe Ciliberti retweeted
P1!!!!!! @LewisHamilton 🔥🔥🔥🔥
585
16,091
647
103,680
1,491,027
Giuseppe Ciliberti retweeted
🔥 #EuroPCR 2026 Major Late-Breaking Trials: Long-term mortality following PCI with DES versus CABG for left main disease An individual participant data meta-analysis of the SYNTAX, PRECOMBAT, NOBLE and EXCEL trials presented by Brian Bergmark showed no significant difference in all-cause mortality between DES PCI and CABG over 10-year follow-up in patients with left main coronary artery disease suitable for revascularisation. Read the press release here: pcronline.com/News/PCR-Press… @NievesGonzalo1 @CuissetDr @nicolasdumonte1 #LeftMain #PCI #CABG #CoronaryArteryDisease #InterventionalCardiology #ClinicalTrials
25
2
32
9,954
Giuseppe Ciliberti retweeted
#EuroPCR 2026 Major Late-Breaking Trials: Coronary revascularisation in patients undergoing TAVI This meta-analysis, presented by @MdScarsini provides the most comprehensive individual participant data metaanalysis to date concerning the role of coronary revascularisation in patients with AS and CAD undergoing TAVI. The findings indicate that routine PCI provides limited advantage compared with medical therapy. A strategy of selective, physiology-guided PCI may be beneficial for patients with severe aortic stenosis and CAD undergoing hashtag#TAVI. Read press release 🔗pcronline.com/News/PCR-Press… @CuissetDr @NievesGonzalo1 @nicolasdumonte1 #latebreakingtrials #interventionalcardiology #clinicalresearch #science
11
20
856
Giuseppe Ciliberti retweeted
As TAVI expands to younger and more complex patients, preventing coronary obstruction is becoming increasingly important. This review summarised evolving leaflet modification strategies — from BASILICA to ShortCut and UNICORN — aimed at improving procedural safety in high-risk TAVI and valve-in-valve interventions. #CardioTwitter #TAVI #BASILICA #StructuralHeart eurointervention.pcronline.c… @sunnygoelmd @GilbertTangMD
1
63
1
124
8,668
Giuseppe Ciliberti retweeted
In patients with non–LM bifurcation lesions a conservative strategy without systematic side branch intervention is associated with very rare procedural complications and is noninferior to a systematic side branch intervention regarding MI jacc.org/doi/10.1016/j.jcin.…
1
35
5
104
13,759
Giuseppe Ciliberti retweeted
A Little trick to save the radial access for an arterial line after #PCI, thanks to @GianlucaCampo78 for the idea! – at Ferrara, Emilia Romagna
29
166
16
698
158,818
Giuseppe Ciliberti retweeted
After TAVI, invasively measured transvalvular gradients—but not echocardiography-derived gradients— were associated with mortality up to 2 years. Echocardiography systematically overestimated gradients, particularly with balloon-expandable valves. Read more in our #EIJBestOf 👇 #CardioTwitter #TAVI 🔗eurointervention.pcronline.c… @RikAdrMD @verhemel @Rjnuis @JoostDaemen @drnvanmieghem
64
127
10,379
Giuseppe Ciliberti retweeted
Early surgery in asymptomatic patients with very severe aortic stenosis led to a lower risk of a composite of operative mortality or death from cardiovascular causes at 10 years than conservative care. Full RECOVERY trial results: nejm.org/doi/full/10.1056/NE…
6
155
10
485
61,798
Giuseppe Ciliberti retweeted
PCI before TAVI—necessary? In patients with CAD, deferring PCI was noninferior to a PCI-first strategy at 1 year for the composite of death, MI, stroke, and major bleeding. spkl.io/6018A0C78 #ACC26
72
5
197
23,077
Giuseppe Ciliberti retweeted
Presented at #ACC26: Among patients with unprotected left main coronary artery disease, intravascular ultrasonography–guided PCI did not result in a lower risk of ischemic events or death than angiography-guided PCI. Full OPTIMAL trial results: nejm.org/doi/full/10.1056/NE… Editorial: Seeing the Left Main Coronary Artery Clearly — Is IVUS Always Necessary? nejm.org/doi/full/10.1056/NE… @ACCinTouch
1
78
14
174
54,612
Giuseppe Ciliberti retweeted
Presented at #ACC26: In the IVUS-CHIP trial involving patients undergoing complex high-risk PCI, the risk of target-vessel failure (a composite outcome) was not lower with intravascular ultrasound guidance than with angiography guidance. Full trial results: nejm.org/doi/full/10.1056/NE… Editorial: IVUS — A Zigzag Path to Success nejm.org/doi/full/10.1056/NE… @ACCinTouch
3
32
5
99
32,043
Giuseppe Ciliberti retweeted
In this RCT of complex bifurcation #PCI using DK crush technique, 1-year benefits of #IVUS-guided PCI were driven by achieving IVUS optimization targets, not IVUS use alone. jacc.org/doi/10.1016/j.jacc.… #JACC #ACC26
21
2
67
6,108
Giuseppe Ciliberti retweeted
Presented at #ACC26: In the ALL-RISE trial, FFRangio (fractional flow reserve derived from angiography) was noninferior to pressure-wire–guided assessment in reducing risk among patients with intermediate coronary stenosis. Full trial results: nejm.org/doi/full/10.1056/NE… Editorial: Toward Broader Adoption of Coronary Physiological Assessment nejm.org/doi/full/10.1056/NE… @ACCinTouch
1
48
3
120
33,869